Shanghai – September 11, 2026 -- CorrectSequence Therapeutics (Correctseq) reported that its transformer Base Editor (tBE) therapy CS-101/CS-206 achieved full transfusion independence or elimination of vaso-occlusive crises (VOC) in four new patients from Nigeria, Laos, Malaysia and Pakistan, expanding on earlier results in five Chinese patients who all reached transfusion independence.

Palo Alto, Calif. – September 11, 2026 -- Prezent Vivo, an AI-powered communication platform for the life sciences sector, has appointed Alice Choi as Chief Operating Officer, adding more than 30 years of medical communications experience to its leadership team.

Sheridan – September 11, 2026 -- The global pharmaceutical contract development and manufacturing organization (CDMO) market is forecast to expand from $191 billion in 2026 to $270.3 billion by 2031, a compound annual growth rate of 7.2%, according to a new study by Wissen Research.

Las Vegas – – September 11, 2026 -- The sarcoidosis treatment market across the seven major markets is projected to expand steadily through 2036, driven by a pipeline of seven late- and mid-stage drug candidates targeting a disease that affects an estimated 150,000 to 200,000 patients annually in the United States alone, according to a new market report from DelveInsight.

Shanghai – September 11, 2026 -- Natural Field has expanded its NF TriSolve® nutraceutical solution platform into the sleep wellness category, launching NF TriSolve® SleepRestore Complex after preclinical testing showed a 39% improvement in sleep performance versus a model control group.

Shanghai – September 11, 2026 -- Natural Field has extended its NF TriSolve® nutraceutical solutions platform into the sleep wellness category with the launch of the NF TriSolve® SleepRestore complex.

Carmiel, Israel – September 11, 2026 -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) confirmed that Chief Financial Officer Gilad Mamlok will represent the company at two investor conferences in New York City this month.

Mamlok addresses H.C. Wainwright's 28th Annual Global Investment Conference on September 14

The presentation is scheduled for 2:00 p.m. EDT during the three-day event running September 14-16, 2026.

Delray Beach – – September 11, 2026 -- The global carboxymethylcellulose calcium market will grow from $0.06 billion in 2026 to $0.09 billion by 2036, expanding at a compound annual growth rate of 4.8%, according to a new MarketsandMarkets forecast.

Tel Aviv – – September 11, 2026 -- The Israel National Biotech Innovation Center (INBI) officially launched operations, uniting 15 of Israel's top universities, research institutions and healthcare organizations under a single translational platform for the first time.

Rockville, Maryland – September 11, 2026 -- REGENXBIO Inc. (Nasdaq: RGNX) will hold fireside chats at two major investor healthcare conferences in New York this month.

REGENXBIO confirms back-to-back fireside chats on September 15 and 16

The gene therapy company will participate in the Baird 2026 Global Healthcare Conference on Tuesday, September 15 at 8:30 a.m. ET, followed by the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16 at 8:30 a.m. ET. Both sessions will take place in New York, NY.